4594.T
BrightPath Biotherapeutics Co.,Ltd.
グロース · 医薬品 · 医薬品 · JP
JPY 52.00
+0.00%Income statement
| Metric | TTM | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 1.0M | — | 1.0M | — | 5.0M |
| Cost of Revenue | 8.0K | 29.0K | — | 18.0K | — |
| Gross Profit | 25.0K | 54.0K | — | 54.0K | — |
| Operating Expenses | |||||
| R&D Expense | — | — | — | — | — |
| SG&A Expense | 956.6M | 1.3B | — | 1.2B | — |
| General & Admin Expense | — | — | — | — | — |
| Selling & Marketing Expense | — | — | — | — | — |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 956.6M | 1.3B | — | 1.2B | — |
| Cost and Expenses | 1.3B | 1.3B | 1.2B | 1.2B | 1.5B |
| Operating Income (EBIT) | (1.3B) | (1.3B) | (1.2B) | (1.2B) | (1.5B) |
| Non-Operating | |||||
| Interest Income | 12.0K | 16.0K | — | 12.0K | — |
| Interest Expense | — | — | — | — | — |
| Net Interest Income | — | — | — | — | — |
| Other Non-Op Income/Expense | 3.9M | 1.5M | — | (3.9M) | — |
| Non-Operating Income (excl Interest) | 9.1M | 18.0M | — | 287.0K | — |
| EBT (Pre-Tax Income) | (953.3M) | (1.3B) | — | (1.2B) | — |
| Income Tax Expense | 1.8M | 2.4M | — | 1.9M | — |
| Bottom Line | |||||
| Net Income | (1.3B) | (1.3B) | (1.2B) | (1.2B) | (1.5B) |
| Earnings from Cont. Ops | — | — | — | — | — |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (1.3B) | (1.3B) | (1.2B) | (1.2B) | (1.5B) |
| Per Share | |||||
| Basic EPS | (¥14) | (¥12) | (¥14) | (¥18) | (¥25) |
| Diluted EPS | (¥14) | (¥12) | — | — | — |
| Revenue Per Share | ¥0 | ¥0 | ¥0 | ¥0 | ¥0 |
| Shares | |||||
| Basic Shares Outstanding | 105.3M | 111.6M | 81.5M | 64.2M | 59.7M |
| Diluted Shares Outstanding | — | — | — | — | — |
| Profitability Metrics | |||||
| EBITDA | — | — | — | (1.2B) | — |
| D&A | — | — | — | 395.0K | — |
| EBIT | (1.3B) | (1.3B) | (1.2B) | (1.2B) | (1.5B) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026